HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host disease.

Abstract
Granulocyte colony-stimulating factor (G-CSF) is routinely used to collect peripheral blood stem cells (PBSCs) from healthy donors for allogeneic hematopoietic stem cell transplantation (allo-HSCT). We show that, in both humans and mice, G-CSF mobilizes a subset of CD34(+) cells with mature monocyte features. These cells, which are phenotypically and functionally conserved in mice and humans, are transcriptionally distinct from myeloid and monocytic precursors but similar to mature monocytes and endowed with immunosuppressive properties. In response to interferon-γ released by activated T cells, these cells produce nitric oxide, which induces allogeneic T cell death both in vitro and in vivo. These apoptotic T cells are engulfed by macrophages that release transforming growth factor-β and promote regulatory T cell expansion. Indeed, the fraction of CD34(+) monocytes in peripheral blood CD34(+) cells inversely correlates with the incidence of acute graft-versus-host disease (GVHD) in humans. Therefore, G-CSF-mobilized cells are an attractive candidate population to be expanded ex vivo for cellular therapy against GVHD.
AuthorsMaud D'Aveni, Julien Rossignol, Tereza Coman, Shivajanani Sivakumaran, Stephen Henderson, Teresa Manzo, Pedro Santos e Sousa, Julie Bruneau, Guillemette Fouquet, Flora Zavala, Olinda Alegria-Prévot, Meriem Garfa-Traoré, Felipe Suarez, Hélène Trebeden-Nègre, Mohamad Mohty, Clare L Bennett, Ronjon Chakraverty, Olivier Hermine, Marie-Thérèse Rubio
JournalScience translational medicine (Sci Transl Med) Vol. 7 Issue 281 Pg. 281ra42 (Apr 01 2015) ISSN: 1946-6242 [Electronic] United States
PMID25834108 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015, American Association for the Advancement of Science.
Chemical References
  • Antigens, CD34
  • Granulocyte Colony-Stimulating Factor
  • Nitric Oxide
  • Interferon-gamma
  • Nitric Oxide Synthase Type II
Topics
  • Animals
  • Antigens, CD34 (metabolism)
  • Apoptosis (drug effects)
  • Cell Proliferation (drug effects)
  • Graft vs Host Disease (immunology)
  • Granulocyte Colony-Stimulating Factor (pharmacology)
  • Hematopoietic Stem Cell Mobilization
  • Humans
  • Immune Tolerance (drug effects)
  • Immunosuppression Therapy
  • Interferon-gamma (pharmacology)
  • Lymphocyte Activation (drug effects, immunology)
  • Mice
  • Monocytes (drug effects, metabolism)
  • Nitric Oxide (biosynthesis)
  • Nitric Oxide Synthase Type II (metabolism)
  • T-Lymphocytes, Regulatory (cytology, drug effects)
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: